Tag: DARPA

2 articles

Research

DARPA is funding non-invasive neuroplasticity technology

DARPA's Defense Sciences Office has posted Special Notice DARPA-SN-26-111 for its forthcoming SHINE (Selective Harnessing of Intrinsic Neuroplasticity Engineering) Disruption Opportunity, with a prerecorded Information Session webcast on 25 August 2026 and the DO release anticipated the same month. Program manager is Robin Bonomi. SHINE aims to non-invasively induce adaptive neuroplasticity in targeted dysfunctional neural circuits for injury recovery, spanning five modality domains. Awards will be Other Transactions for prototype projects. Registration closes 14 August 2026 and is unusually open to foreign nationals.

Aug 11

Market Moves

Nia Therapeutics gets FDA Breakthrough Designation for a preclinical TBI memory implant

Nia Therapeutics, an Allston Massachusetts company co-founded in 2018 by University of Pennsylvania memory neuroscientist Michael Kahana and cognitive neuromodulation researcher Daniel Rizzuto, received FDA Breakthrough Device Designation on 13 March 2026 for its Smart Neurostimulation System (SNS), indicated for episodic memory loss in adults with prior moderate-to-severe traumatic brain injury. The SNS is a 60-channel wireless closed-loop cortical implant whose platform hardware was validated in a sheep study published in Brain Stimulation in December 2025. It is preclinical: no human implant yet, IDE application planned for 2026.

Jul 5